- Home
- CWEN vs STVN Comparison
CWEN vs STVN Comparison
Compare CWEN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWEN | STVN |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Containers/Packaging |
| Sector | Utilities | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 5.7B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CWEN | STVN |
|---|---|---|
| Price | $30.70 | $21.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $42.00 | $25.67 |
| AVG Volume (30 Days) | ★ 1.1M | 351.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.71% | 0.39% |
| EPS Growth | ★ 11.94 | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $1,429,000,000.00 | N/A |
| Revenue This Year | $16.38 | $9.67 |
| Revenue Next Year | $8.48 | $9.99 |
| P/E Ratio | $41.28 | ★ $27.15 |
| Revenue Growth | ★ 4.23 | N/A |
| 52 Week Low | $27.90 | $12.89 |
| 52 Week High | $41.74 | $28.00 |
Technical Indicators
Market Signals| Indicator | CWEN | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 39.50 | 56.42 |
| Support Level | N/A | $20.17 |
| Resistance Level | $33.87 | $22.00 |
| Average True Range (ATR) | 0.78 | 0.87 |
| MACD | -0.11 | 0.09 |
| Stochastic Oscillator | 17.95 | 60.90 |
Price Performance
Historical ComparisonAbout CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and the owner of modern, sustainable, and long-term contracted assets across North America. The company segments its operations into Flexible Generation, Renewables & Storage, and Corporate divisions. The majority of its revenue is generated from the Renewables & Storage segment.
About STVN Stevanato Group S.p.A.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.